Plain-English translation of NCT07302360 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is studying how well guselkumab works for people with moderate-to-severe ulcerative colitis (a long-term condition causing inflammation and ulcers in the colon) in everyday Chinese medical settings. Researchers will collect information from patients' medical records and regular doctor visits to see how this medication helps people feel better and improves their symptoms. This is not a study where you receive the medication as part of the trial—instead, you'll be treated by your regular doctor, and the researchers will simply track how you do.
Ulcerative colitis can be very difficult to manage, and patients need to know which newer treatments work best in real-world conditions outside of controlled research settings. This study will help doctors and patients in China understand whether this medication is an effective option for people who haven't tried other advanced therapies yet.
You likely qualify if…
You likely don't qualify if…
Your regular doctor will prescribe and manage your guselkumab treatment according to standard medical care—the research team will not provide the medication. During your normal clinic visits, researchers will collect information from your medical records about how you're doing, how your symptoms are changing, and how the treatment is affecting your quality of life. The study will follow you over time as you receive this treatment in the real-world setting of your doctor's office or clinic.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
China